PT1268463E - 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao - Google Patents

4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao

Info

Publication number
PT1268463E
PT1268463E PT01923149T PT01923149T PT1268463E PT 1268463 E PT1268463 E PT 1268463E PT 01923149 T PT01923149 T PT 01923149T PT 01923149 T PT01923149 T PT 01923149T PT 1268463 E PT1268463 E PT 1268463E
Authority
PT
Portugal
Prior art keywords
polycyclic
cascade
heteroaryl
substituted
coagulacao
Prior art date
Application number
PT01923149T
Other languages
English (en)
Inventor
William L Neumann
Michael S South
Chun C Ma
Kevin J Koeller
Hayat K Rahman
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of PT1268463E publication Critical patent/PT1268463E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
PT01923149T 2000-04-05 2001-04-04 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao PT1268463E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19491500P 2000-04-05 2000-04-05
US25215700P 2000-11-20 2000-11-20

Publications (1)

Publication Number Publication Date
PT1268463E true PT1268463E (pt) 2005-05-31

Family

ID=26890524

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01923149T PT1268463E (pt) 2000-04-05 2001-04-04 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao

Country Status (10)

Country Link
US (4) US6875791B2 (pt)
EP (1) EP1268463B1 (pt)
JP (1) JP2004505014A (pt)
AT (1) ATE289299T1 (pt)
AU (1) AU2001249870A1 (pt)
CA (1) CA2405561A1 (pt)
DE (1) DE60108948T2 (pt)
ES (1) ES2236211T3 (pt)
PT (1) PT1268463E (pt)
WO (1) WO2001077097A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068605A1 (en) 2000-03-13 2001-09-20 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
US6875791B2 (en) 2000-04-05 2005-04-05 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
EP1351686A2 (en) * 2000-11-20 2003-10-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
WO2003093242A2 (en) 2001-10-03 2003-11-13 Pharmacia Corporation Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
CA2462305A1 (en) 2001-10-03 2003-04-10 Michael S. South 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
US8753124B2 (en) * 2009-02-15 2014-06-17 Cheryl Lynn Evans Method and apparatus for prescribing and preparing a reproducible and customized dysphagia diet
WO2015085238A1 (en) * 2013-12-05 2015-06-11 The Regents Of The University Of California, A California Corporation Inhibitors of lpxc

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5910541A (ja) * 1982-07-09 1984-01-20 Takeda Chem Ind Ltd キノン化合物
JPS60255749A (ja) * 1984-05-31 1985-12-17 Univ Nagoya キノン誘導体
US5304658A (en) * 1984-08-01 1994-04-19 Takeda Chemical Industries, Ltd. Quinone derivatives, their production and use
IL81264A (en) * 1986-01-30 1990-11-05 Takeda Chemical Industries Ltd Quinone derivatives,their production and pharmaceutical compositions containing them
DE3826846A1 (de) 1988-08-06 1990-02-08 Goedecke Ag Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5008267A (en) 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JPH05501886A (ja) * 1990-06-29 1993-04-08 ジ・アップジョン・カンパニー 抗アテローム性動脈硬化症性および抗血栓性２―アミノ―６―フェニル―４ｈ―ピラン―４―オン類
GB9216272D0 (en) 1991-08-15 1992-09-09 Ici Plc Substituted heterocycles
US5441960A (en) * 1992-04-16 1995-08-15 Zeneca Limited 1-pyrimidinylacetamide human leukocyte elastate inhibitors
WO1993021214A1 (en) 1992-04-16 1993-10-28 Zeneca Limited Alpha-aminoboronic acid peptides and their use as elastase inhibitors
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US5656645A (en) * 1994-12-13 1997-08-12 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US6011158A (en) 1994-12-13 2000-01-04 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5658930A (en) * 1994-12-13 1997-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
ATE217321T1 (de) 1994-12-13 2002-05-15 Corvas Int Inc Aromatische heterocyclische derivate als enzyminhibitoren
WO1996033974A1 (fr) 1995-04-27 1996-10-31 The Green Cross Corporation Composes heterocycliques amides et leur utilisation medicinale
US5612378A (en) 1995-06-06 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors
US5741819A (en) 1995-06-07 1998-04-21 3-Dimensional Pharmaceuticals, Inc. Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
CA2224437A1 (en) 1995-06-27 1997-01-16 Merck & Co., Inc. Pyridinone-thrombin inhibitors
JP2921606B2 (ja) 1995-11-08 1999-07-19 ケーニツヒ ウント バウエル−アルバート アクチエンゲゼルシヤフト 折り装置
EP0923372A4 (en) 1996-02-22 2001-09-05 Merck & Co Inc PYRIDINONE THROMBINE INHIBITORS
JP3140790B2 (ja) 1996-04-23 2001-03-05 メルク エンド カンパニー インコーポレーテッド ピラジノン系トロンビン阻害薬
US5668289A (en) * 1996-06-24 1997-09-16 Merck & Co., Inc. Pyridinone thrombin inhibitors
EP0934305A4 (en) 1996-08-29 2001-04-11 Merck & Co Inc INTEGRINE ANTAGONISTS
WO1998009987A1 (en) 1996-09-06 1998-03-12 Biochem Pharma, Inc. Lactam inhibitors of thrombin
CN1169791C (zh) 1996-09-06 2004-10-06 日本化药株式会社 新颖的乙酰胺衍生物和蛋白酶抑制剂
AU725403B2 (en) 1996-09-13 2000-10-12 Merck & Co., Inc. Thrombin inhibitors
US5872138A (en) * 1996-09-13 1999-02-16 Merck & Co., Inc. Thrombin inhibitors
CA2268264A1 (en) 1996-10-11 1998-04-23 Cor Therapeutics, Inc. Selective factor xa inhibitors
AU743735B2 (en) 1996-10-11 2002-02-07 Millennium Pharmaceuticals, Inc. Selective factor Xa inhibitors
US5869487A (en) * 1996-10-24 1999-02-09 Merck & Co., Inc. Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
JP2001502691A (ja) 1996-10-24 2001-02-27 メルク エンド カンパニー インコーポレーテッド トロンビン阻害剤
US6080738A (en) 1996-10-25 2000-06-27 Yoshitomi Pharmaceuticals Industries, Ltd. Heterocyclic amide compounds and medicinal uses thereof
JP2001508796A (ja) 1997-01-22 2001-07-03 メルク エンド カンパニー インコーポレーテッド トロンビン阻害薬
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
EP0969840A4 (en) 1997-03-24 2001-02-28 Merck & Co Inc THROMBIN INHIBITORS
US5866573A (en) * 1997-04-21 1999-02-02 Merck & Co., Inc. Pyrazinone thrombin inhibitors
IL123986A (en) 1997-04-24 2011-10-31 Organon Nv Medicinal compounds
PT979240E (pt) 1997-05-02 2004-08-31 Akzo Nobel Nv Inibidores de serina-protease
IL133627A0 (en) 1997-06-26 2001-04-30 Lilly Co Eli Antithrombotic agents
ES2241151T3 (es) 1997-06-26 2005-10-16 Eli Lilly And Company Agentes antitromboticos.
IL133621A0 (en) 1997-06-26 2001-04-30 Lilly Co Eli Antithrombotic agents
JP2001514227A (ja) 1997-09-05 2001-09-11 メルク エンド カムパニー インコーポレーテッド ピラジノン系トロンビン阻害薬
AU1605699A (en) 1997-11-26 1999-06-15 Corvas International, Inc. Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii)
JP2001524467A (ja) 1997-11-26 2001-12-04 ３−ディメンショナル ファーマシューティカルズ， インコーポレイテッド ヘテロアリールアミノグアニジンおよびアルコキシグアニジンおよびプロテアーゼインヒビターとしてのこれらの使用
ATE232536T1 (de) 1998-01-20 2003-02-15 Warner Lambert Co N-(2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-
WO1999043660A1 (en) 1998-02-26 1999-09-02 Neurogen Corporation Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
GB9806102D0 (en) 1998-03-20 1998-05-20 Merck Sharp & Dohme Therapeutic agents
JP2002515434A (ja) 1998-05-19 2002-05-28 メルク エンド カムパニー インコーポレーテッド ピラジノン系トロンビン阻害薬
CA2333040A1 (en) 1998-05-26 1999-12-02 Merck & Co., Inc. Imidazopyridine thrombin inhibitors
EP1135151A4 (en) 1998-06-03 2002-01-02 Cortech Inc ALPHA-KETO OXADIAZOLE CONTAINING PEPTOIDS AND NON-PEPTOIDS AS SERINE PROTEASE INHIBITORS
IL139867A0 (en) 1998-06-11 2002-02-10 Dimensional Pharm Inc Pyrazinone derivatives and pharmaceutical compositions containing the same
DE69912379T2 (de) * 1998-08-14 2004-05-06 Pfizer Inc. Antithrombosemittel
CA2343109A1 (en) 1998-09-28 2000-04-06 Merck & Co., Inc. Thrombin inhibitors
AU752186B2 (en) 1998-10-30 2002-09-12 Merck & Co., Inc. Thrombin inhibitors
CA2348734A1 (en) 1998-10-30 2000-05-11 Merck & Co., Inc. Thrombin inhibitors
DE19851421A1 (de) 1998-11-07 2000-05-11 Boehringer Ingelheim Pharma Neue Pyrimidine, deren Herstellung und Verwendung
FR2786482B1 (fr) 1998-11-27 2002-08-09 Synthelabo Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
AU3127900A (en) 1998-12-23 2000-07-31 Du Pont Pharmaceuticals Company Thrombin or factor xa inhibitors
AU771740B2 (en) 1999-05-19 2004-04-01 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
HUP0201242A3 (en) 1999-05-19 2003-02-28 Pharmacia Corp St Louis Substituted polycyclic aryl and heteroaryl pyrimidinone and triazinone derivatives useful as anticoagulants and pharmaceutical compositions containing them
KR20010113970A (ko) 1999-05-19 2001-12-28 추후보정 응고 캐스케이드의 선택적 억제에 유용한 치환 폴리시클릭아릴 및 헤테로아릴 피리돈
US6875791B2 (en) 2000-04-05 2005-04-05 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade

Also Published As

Publication number Publication date
US20040006227A1 (en) 2004-01-08
DE60108948T2 (de) 2005-11-03
EP1268463B1 (en) 2005-02-16
US6875791B2 (en) 2005-04-05
US20050165021A1 (en) 2005-07-28
CA2405561A1 (en) 2001-10-18
US20030216451A1 (en) 2003-11-20
DE60108948D1 (de) 2005-03-24
US20020022604A1 (en) 2002-02-21
WO2001077097A2 (en) 2001-10-18
WO2001077097A3 (en) 2002-07-04
ATE289299T1 (de) 2005-03-15
JP2004505014A (ja) 2004-02-19
AU2001249870A1 (en) 2001-10-23
EP1268463A2 (en) 2003-01-02
US6916847B2 (en) 2005-07-12
ES2236211T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
BR0010758A (pt) Aril e heteroaril pirimidinonas policìclicas substituìdas úteis como anti coagulantes
UY26154A1 (es) Aril y heteroaril piridonas policíclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación
BR0011273A (pt) Uracilas de heteroarila e arila policìclica substituìdas como agentes anti-coagulantes
NL300933I2 (nl) Letermovir
AP1744A (en) Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
MEP90508A (en) New pharmaceutical composition
DZ3402A1 (fr) Cyclopentanoindoles, compositions contenant ces composes et methodes de traitement
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
BR0213129A (pt) Pró-drogas de compostos policìclicos substituìdos, úteis para inibição seletiva da cascata da coagulação
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
WO2002042272A3 (en) Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
ATE232873T1 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
BR0011295A (pt) Aril e heteroaril pirazinonas policìclicas substituìdas úteis para inibição seletiva de cascata de coagulação
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
PT1268463E (pt) 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao
WO2002032435A3 (en) A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
NO20055396L (no) Nye fosfonsyreforbindelser som serinproteaseinhibitorer
BR0213099A (pt) Compostos policìclicos de 5 membros substituìdos úteis para inibição seletiva da cascata de coagulação
WO2001079155A3 (en) Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
IS7200A (is) Notkun á írbesartan til framleiðslu á lækningalyfjum sem notuð eru til að koma í veg fyrir eða meðhöndla lungnaháþrýsting
WO2001077079A3 (en) Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
PT1276722E (pt) Inibidores de naftamidina-uroquinase
ECSP003480A (es) Aril policiclico substituido y pirazonas heteroaril utiles para la inhibicion selectiva de la cascada de coagulacion